All Stories

  1. Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study

    Article • Sarcoma, November 2019, Hindawi Publishing Corporation

    MUJTABA KHAN, Dr Nisarg JOSHI

  2. Letter to the editor: ‘current advances in development of new docetaxel formulations’

    Article • Expert Opinion on Drug Delivery, July 2019, Taylor & Francis

    Dr Nisarg JOSHI, MUJTABA KHAN

  3. pregnancy associated breast cancers

    Article • OncoTargets and Therapy, July 2019, Dove Medical Press

    MUJTABA KHAN, rajkumar ramaswamy, Dr Nisarg JOSHI

  4. [Experts' Opinion] Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer

    Article • Oncology Letters, July 2018, Spandidos Publications

    Dr Nisarg JOSHI

  5. Novel Docetaxel Formulation (NDLS) in Low Cardiac Reserve Ovarian Cancer

    Article • Open Access Journal of Cancer & Oncology, January 2018, Medwin Publishers

    Dr Nisarg JOSHI

  6. Efficacy and Safety of a Novel Nanosomal Docetaxel Lipid Suspension as an Anticancer Agent - A Retrospective Study

    Article • Open Access Journal of Cancer & Oncology, January 2018, Medwin Publishers

    Dr Nisarg JOSHI